About: Prevalence, pathogenesis, therapy, and prevention of cardiovascular events in patients with community-acquired pneumonia

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Prevalence, pathogenesis, therapy, and prevention of cardiovascular events in patients with community-acquired pneumonia Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Prevalence, pathogenesis, therapy, and prevention of cardiovascular events in patients with community-acquired pneumonia
Creator	Feldman, Charles Anderson, Ronald
Source	PMC
abstract	It is now well recognised that cardiac events occur relatively commonly in patients with acute community-acquired pneumonia. While these events are more frequent in patients with underlying risk factors—such as those with underlying chronic cardiovascular and respiratory comorbidities, the elderly, and in nursing home residents—they also occur in patients with no underlying risks other than severe pneumonia. Recent research elucidating the underlying pathogenic mechanisms related to these cardiac events has indicated a probable role for platelet activation, which is possibly exacerbated by pneumolysin in the case of pneumococcal infections. This, in turn, has resulted in the identification of possible therapeutic strategies targeting platelet activation, as well as the cardio-toxic activity of pneumolysin. These issues represent the primary focus of the current review.
has issue date	2016-07-21(xsd:dateTime)
bibo:doi	10.1186/s41479-016-0011-0
bibo:pmid	28702290
has license	cc-by
sha1sum (hex)	fa0734c2e4d6db10143a0c0018cf097e884e509e
schema:url	https://doi.org/10.1186/s41479-016-0011-0
resource representing a document's title	Prevalence, pathogenesis, therapy, and prevention of cardiovascular events in patients with community-acquired pneumonia
has PubMed Central identifier	PMC5471702
has PubMed identifier	28702290
schema:publication	Pneumonia (Nathan)
resource representing a document's body	covid:fa0734c2e4d6db10143a0c0018cf097e884e509e#body_text
is schema:about of	named entity 'patients' named entity 'chronic' named entity 'frequent' named entity 'risks' named entity 'patients' named entity 'respiratory' named entity 'Prevalence' named entity 'activation' named entity 'commonly' named entity 'activity' named entity 'represent' named entity 'activation' named entity 'cardiac' named entity 'current' named entity 'patients' named entity 'therapy' named entity 'cardiac events' named entity 'risk factors' named entity 'pneumococcal infections' named entity 'CAP' named entity 'vascular endothelium' named entity 'phosphorylcholine' named entity 'upregulated' named entity 'immunogenicity' named entity 'platelet' named entity 'platelet count' named entity 'cardiac events' named entity 'Musher' named entity 'observational study' named entity 'multivariate analysis' named entity 'coagulation' named entity 'immunisation' named entity 'CHF' named entity 'CAP' named entity 'pro-inflammatory' named entity 'anti-platelet' named entity 'confounding' named entity 'cardiac complications' named entity 'ischaemic stroke' named entity 'antibiotics' named entity 'electrocardiographic' named entity 'CAP' named entity 'Community-Acquired Pneumonia' named entity 'hyperlipidaemia' named entity 'cardiac complications' named entity 'CAP' named entity 'CHF' named entity 'endothelial' named entity 'ALI' named entity 'experimental animal' named entity 'ARDS' named entity 'pneumococcal pneumonia' named entity 'enzyme' named entity 'murine' named entity 'follow-up' named entity 'histone' named entity 'systematic review' named entity 'CHF' named entity 'influenza' named entity 'cohort studies' named entity 'platelet count' named entity 'risk factors' named entity 'immunisation' named entity 'CAP' named entity 'endothelial' named entity 'cardiac event' named entity 'vaccine' named entity 'CAP' named entity 'prospective study' named entity 'sepsis' named entity 'PCV13' named entity 'IPD' named entity 'CAP' named entity 'neutrophils' named entity 'comorbidities' named entity 'respiratory symptoms' named entity 'thromboxane' named entity 'platelet activation' named entity 'pneumococcus' named entity 'integrin'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software